Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 165-170

  Hojo, Yukihiro ^a   Ikeda, Uichi ^a   Katsuki, Taka Aki ^a   Mizuno, Osamu ^a   Fukazawa, Hiroshi ^a   Fujikawa, Hideyuki ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angioplasty; Leukocytes; Restenosis

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATHERECTOMY; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY SINUS BLOOD FLOW; FEMALE; HUMAN; LEFT CORONARY ARTERY; MALE; MONONUCLEAR PHAGOCYTE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESTENOSIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; CHEMOKINES; CORONARY DISEASE; FEMALE; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RECURRENCE; STENTS; TIME FACTORS;

EID: 0035022277     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00611-0     Document Type: Article

References (31)

1. Ikeda U., Ohkawa F., Seino Y., Yamamoto K., Hidaka Y., Kasahara T., Kawai T., Shimada K. Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol. 24:1992;579-584.
2. Tashiro H., Shimokawa H., Yamamoto K., Nagano M., Momohara M., Muramatsu K., Takeshita A. Monocyte-related cytokines in acute myocardial infarction. Am Heart J. 130:1995;446-452.
3. Kukielka G.L., Smith W., Manning A.M., Youker K.A., Michael L.H., Entman M.L. Induction of interleukin-6 synthesis in the myocardium; potential role in postperfusion inflammatory injury. Circulation. 92:1995;1866-1875.
4. Herskowitz A., Choi S., Ansari A.A., Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 146:1995;419-428.
5. Wan S., DeSmet J.M., Barvais L., Goldstein M., Vincent J.L., LeClerc J.L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 112:1996;806-811.
6. Guillén I., Blanes M., Gómez Lechón M.J., Castell J.V. Cytokine signaling during myocardial infarction: sequential appearance of IL-1? and IL-6. Am J Physiol. 269:1995;R229-R235.
7. Kanda T., Hirao Y., Oshima, Yuasa K., Taniguchi K., Nagai R., Kobayashi I. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol. 77:1996;304-307.
8. Kukielka G.L., Smith W., LaRosa G.J., Manning A.M., Mendoza L.H., Daly T.J., Hughes B.J., Youker K.A., Hawkins H.K., Michael L.H., Rot A., Entman M.L. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest. 95:1995;89-103.
9. Neumann F.J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., Schömig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 92:1995;748-755.
10. Biasucci L.M., Vitelli A.A., Liuzzo G., Altamura S., Caligiuri G., Monaco, Rebuzzi A.G., Caligiuri G., Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874-877.
11. Marx N., Neuman F.J., Ott I., Gawaz M., Koch W., Pikau T., Schömig A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol. 30:1997;165-170.
12. Ott I., Neuman F.J., Kenngott S., Gawaz M., Schömig A. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol. 82:1998;938-942.
13. Serrano C.V., Ramires J.A.F., Venturinelli M., Arie S., D'amico E., Zweier J.L., Pileggi F., Luz P.L. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. J Am Coll Cardiol. 29:1997;1276-1283.
14. Blum A., Sclarovsky S., Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation. 91:1995;20-22.
15. Liuzzo G., Buffon A., Biasucci L.M., Gallimore R., Caligiuri G., Vitelli A., Altamura S., Ciliberto G., Rebuzzi A.G., Crea F., Pepys M.B., Maseri A. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 98:1998;2370-2376.
16. Libby P., Schwartz D., Brogi E., Tanaka H., Clinton S.K. A cascade model for restenosis. a special case of atherosclerosis progression. Circulation. 86:(Suppl. 3):1992;3-47-52.
17. Piek J.J., VanDerWal A.C., Meuwissen M., Koch K.T., Chamuleau S.A.J., Teeling P., VanDerLoos C.M., Becker A.E. Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. J Am Coll Cardiol. 35:2000;963-967.
18. Moreno P.R., Bernardi V.H., Lopez-Cuellar J., Newell J.B., McMellon C., Gold H.K., Palacios I.F., Fuster V., Fallon J.T. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation. 94:1996;3098-3102.
19. Mizuno O., Hojo Y., Ikeda U., Katsuki T., Fukazawa H., Kurosaki K., Fujikawa H., Shimada K. Assessment of coagulation and platelet activation in coronary sinus blood induced by transcatheter coronary intervention for narrowing of the left anterior descending coronary artery. Am J Cardiol. 85:2000;154-160.
20. Gimple L.W., Herrmann H.C., Winnford M., Mammen E. For the Ardeparin and Restenosis Study Group. Usefulness of subcutaneous low molecular weight heparin (Ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 83:1999;1524-1529.
21. Krishnaswamy G., Kelly J., Yerra L., Smith J.K., Chi D.S. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 19:1999;91-104.
22. Schrader J.W., Moyer C., Ziltener H.J., Reinisch C.L. Release of the cytokines colony-stimulating factor, and IL-6 by cloned murine vascular smooth muscle cells. J Immunol. 146:1991;3799-3808.
23. Pietersma A., Kofflard M., deWit E.A., Stijnen T., Koster J.F., Serruys P.W., Sluiter W. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 91:1995;1320-1325.
24. Evans R., Kamdar S.J., Fuller J.A., Krupke D.M. The potential role of the macrophage colony-stimulating factor, CSF-1, in inflammatory responses: characterization of macrophage cytokine gene expression. J Leukoc Biol. 58:1995;99-107.
25. Tashiro H., Shimokawa H., Yamamoto K., Momohara M., Tada H., Takeshita A. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis. 8:1997;143-147.
26. Rajavashisth T., Qiao J.H., Tripathi S., Tripathi J., Mishra N., Hua M., Wang X.P., Loussararian A., Clinton S., Libby P., Lusis A. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 15:1998;2702-2710.
27. Saitoh T., Kishida H., Tsukada Y., Fukuma Y., Sano J., Yasutake M., Fukuma N., Kusama Y., Hayakawa H. Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris. J Am Coll Cardiol. 35:2000;655-665.
28. Mozes G., Mohacsi T., Gloviczki P., Menawat S., Kullo I., Spector D., Taylor J., Crotty T.B., O'Brien T. Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo. Arterioscler Thromb Vasc Biol. 18:1998;1157-1163.
29. Murayama T., Yokode M., Kataoka H., Imabayashi T., Yoshida H., Sano H., Nishikawa S., Kita T. Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice. Circulation. 99:1999;1740-1746.
30. Jordan N.J., Watson M.L., Williams R.J., Roach A.G., Yoshimura T., Westwick J. Chemokine production by human vascular smooth muscle cells; modulation by IL-13. Br J Pharmacol. 122:1997;749-757.
31. Shyy Y.J., Wickham L.L., Hagen J.P., Hsieh H.J., Hu Y.L., Telian S.H., Valente A.J., Sung K.L., Chien S. Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemoatractic protein-1 and increases the adhesion of monocytes to endothelial monolayer. J Clin Invest. 92:1993;1745-1751.